| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/20/1992 | WO1991019743A3 Combined treatment with gnrh antagonist and gnrh to control gonadotropin levels in mammals |
| 02/20/1992 | WO1991019736A3 Cancer-associated scm-recognition factor, preparation and method of use |
| 02/20/1992 | WO1991019734A3 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 02/20/1992 | WO1991012824A3 19f labelled compounds as nmr imaging and spectroscopy agents |
| 02/20/1992 | WO1991004059A3 Method and useful apparatus for preparing pharmaceutical compositions |
| 02/20/1992 | DE4122094A1 1,1,3,3,-Bis-polymethylene-2-(hetero)aryl-uronium salts - are condensn. agents with improved solubility properties, esp. for use in automated peptide syntheses |
| 02/20/1992 | CA2088990A1 Chimeric neurotrophic factors |
| 02/20/1992 | CA2088489A1 Carbohydrate-based anti-inflammatory agents |
| 02/20/1992 | CA2088246A1 Gene encoding equine herpesvirus type i glycoprotein d, its gene product, antibodies and their uses |
| 02/20/1992 | CA2088164A1 Nuclear phosphoproteins for prognosticating lymphoid or epithelial cancers |
| 02/19/1992 | EP0471651A2 Peptide boronic acid derivatives having protease inhibiting activity |
| 02/19/1992 | EP0471564A2 Translational enhancement in pseudomonas |
| 02/19/1992 | EP0471514A2 Improved bacteriophage lambda pL promoters |
| 02/19/1992 | EP0471457A2 Herpesvirus-based viral vector which expresses a foot & mouth disease virus epitope |
| 02/19/1992 | EP0471453A2 Cyclic HIV principal neutralizing determinant peptides |
| 02/19/1992 | EP0471407A2 New embodiments of the HIV principal neutralizing determinant |
| 02/19/1992 | EP0471356A1 Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof |
| 02/19/1992 | EP0471028A1 Highly cytopathogenic hiv-ndk retrovirus, dna fragments of this retrovirus, method for preparing a protein and/or an enzyme of this virus, and the applications of these |
| 02/19/1992 | EP0470999A1 Method and vectors for stabilizing heterologous protein expression |
| 02/19/1992 | EP0470974A1 Lytic peptides, use for growth, infection and cancer |
| 02/19/1992 | CN1058846A Method for qualitative and quanitative determination of polypeptides and proteins in solutions and biological fluids |
| 02/19/1992 | CN1058782A Epitheliins: novel cysteine-rich growth modulating proteins |
| 02/19/1992 | CN1015512B Tangential flow affinity ultrafiltration |
| 02/18/1992 | WO1992003542A1 PROTEASES CAUSING ABNORMAL DEGRADATION OF AMYLOID β-PROTEIN PRECURSOR |
| 02/18/1992 | WO1992003478A1 Metal ion mediated receptor binding of polypeptide hormones |
| 02/18/1992 | WO1992003159A1 New peptides and their use |
| 02/18/1992 | US5089605 Immobilized immunoglobulin-binding proteins |
| 02/18/1992 | US5089602 Process for the manufacture of apolipoproteins from human blood plasma or serum |
| 02/18/1992 | US5089474 Solid phase synthesis, anti-elastase activity |
| 02/18/1992 | US5089473 Somatotropin variants and their use |
| 02/18/1992 | US5089419 Detection of pregnancy by identification of the c peptide of relaxin in the urine of animals |
| 02/18/1992 | US5089406 Method of producing a gene cassette coding for polypeptides with repeating amino acid sequences |
| 02/18/1992 | US5089400 Recombinant DNA which produces lymphoblastoid interferon-like polypeptides, useful as immunomodulators |
| 02/18/1992 | US5089398 Enhanced yeast transcription employing hybrid GAPDH promoter region constructs |
| 02/18/1992 | US5089397 Superior mammalian expression system |
| 02/18/1992 | US5089396 Nucleic acid encoding β chain prodomains of inhibin and method for synthesizing polypeptides using such nucleic acid |
| 02/18/1992 | US5089274 Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
| 02/18/1992 | US5089262 Diagnosis, therapy |
| 02/18/1992 | CA2089660A1 New peptides and their use |
| 02/18/1992 | CA2088776A1 Proteases causing abnormal degradation of amyloid .beta.-protein precursor |
| 02/18/1992 | CA2087267A1 Metal ion mediated receptor binding of polypeptide hormones |
| 02/18/1992 | CA1295985C Method for separating and purifying protein antigens from bordetella bacteria |
| 02/18/1992 | CA1295960C Monoclonal antibody |
| 02/18/1992 | CA1295940C Therapeutic treatment of abnormal cell growth with follicle regulatoryprotein |
| 02/17/1992 | WO1992003455A1 INHIBITION OF $i(CANDIDA) |
| 02/17/1992 | CA2089665A1 Inhibition of candida |
| 02/16/1992 | WO1992003563A1 Method for modifying the cell, tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 02/16/1992 | CA2089484A1 Method for modifying the cell tissue or host tropism of a microorganism; recombinant microorganisms obtained in this way and use thereof in medicine and veterinary medicine |
| 02/15/1992 | WO1992003454A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 02/15/1992 | WO1992003148A1 Improved hypoglycemics |
| 02/15/1992 | WO1992003144A1 Protein structure of the plant toxin gelonin |
| 02/15/1992 | CA2089562A1 Inhibition of influenza virus type a, ann arbor strain h2n2 by antisense oligonucleotides |
| 02/15/1992 | CA2048895A1 Antigenic peptide for detecting anti-hepatitis c virus antibodies and use thereof |
| 02/14/1992 | WO1992003574A1 Cytokine production |
| 02/14/1992 | WO1992003551A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 02/14/1992 | WO1992003476A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/14/1992 | WO1992003466A1 Lymphokine 154 |
| 02/14/1992 | CA2089389A1 Cytokine production |
| 02/14/1992 | CA2089258A1 Lymphokine 154 |
| 02/14/1992 | CA2088972A1 Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| 02/14/1992 | CA2088496A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 02/14/1992 | CA2067182A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 02/14/1992 | CA2048956A1 Bacteriophage lambda pl promoters |
| 02/14/1992 | CA2048953A1 Borolysine peptidomimetics |
| 02/14/1992 | CA2048594A1 Embodiments of the hiv principal neutralizing determinant |
| 02/13/1992 | DE4125188A1 Granulocyten hemmendes polypeptid Granulocyte inhibitory polypeptide |
| 02/12/1992 | EP0470604A2 PACAP38, proteine with adenylate cyclase activity |
| 02/12/1992 | EP0470586A1 Purified recombinant interleukin-2 compositions |
| 02/12/1992 | EP0470565A1 Peptides with antigenic determinant characteristic for alpha 1-microglobulin |
| 02/12/1992 | EP0470520A2 Process for the preparation of peptides or polypeptides in a cell-free translation system |
| 02/12/1992 | EP0470256A1 Peptide derivatives and production thereof |
| 02/12/1992 | EP0470205A1 New human parvovirus peptides with disulfide bridge for immunization or diagnosis |
| 02/12/1992 | EP0470175A1 Enzymatic membrane method for the synthesis and separation of peptides |
| 02/12/1992 | EP0470165A1 Fusion proteins containing n-terminal fragments of human serum albumin |
| 02/12/1992 | EP0470128A1 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 02/12/1992 | EP0470117A1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions. |
| 02/12/1992 | EP0094428B1 Control of dna sequence transcription |
| 02/12/1992 | CN1058597A Process for enzymatic preparation of basic fibroblast growth factor |
| 02/11/1992 | US5087952 Lipid-protein compositions and articles and methods for their preparation |
| 02/11/1992 | US5087696 Conjugate compound |
| 02/11/1992 | US5087694 Fluorinated gelatin and process for its preparation |
| 02/11/1992 | US5087618 Antiviral, anticancer, antitumor agents |
| 02/11/1992 | US5087615 Novel method of ovulation induction in humans |
| 02/11/1992 | US5087614 Inhibits aspartic proteinases |
| 02/11/1992 | US5087613 Hirudin variants |
| 02/11/1992 | US5087572 Anticoagulants |
| 02/11/1992 | US5087571 Culturing cells containing recombinant activated oncogene sequence |
| 02/11/1992 | US5087570 Homogeneous mammalian hematopoietic stem cell composition |
| 02/11/1992 | US5087569 Antimicrobial proteins, compositions containing same and uses thereof |
| 02/11/1992 | US5087564 Preferential cleavage of an e coli rec a fusion protein at the clu-ser junction site of a heterologous peptide |
| 02/11/1992 | US5087563 Plant carrier protein and Staphylococcus fab fragment; fatty acid sythetase; purification |
| 02/11/1992 | US5087562 Humoral hypercalcemic factor antagonists with modification at position 13 . . . |
| 02/11/1992 | US5087561 Humoral hypercalcemic factor antagonists modified at position 13 by biotin |
| 02/11/1992 | US5087453 Method for the treatment of bacterial caused weight loss and/or hypoglycemia |
| 02/11/1992 | US5087369 Absorption using rotation affinity gel carrier |
| 02/11/1992 | US5087368 Purified protease nexin |
| 02/11/1992 | US5087338 Continuous process; improved resolution |
| 02/11/1992 | CA2048899A1 Reducing chelating agents, their technetium and rhenium complexes, process for their production as well as their use in diagnosis and treatment |
| 02/11/1992 | CA2048880A1 Dna and use thereof |
| 02/11/1992 | CA1295567C Expression system for the secretion of bioactive human granulocyte, macrophage-colony stimulating factor (gm-csf) and other heterologous proteins from streptomyces |